Booming Radiopharmaceuticals Industry Attracts Investors
The radiopharmaceutical industry is growing very quickly. In the past few years, there have been more mergers and acquisitions (M&A) and partnerships. Investors can...
FDA Grants Breakthrough Status To GSKs Lung Cancer Drug
The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion agreement last...
Bayer, NextRNA Collaborate On $547Million Cancer Drug Deal
Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug....
Enhancing CLD For Complex Biologics: Important Strategies
The capacity of a cell line to create a biologic that is both safe and stable in large numbers may be considerably improved by...
North American Nuclear Medicine Market Set For Expansion
The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to develop rapidly over the...
Bayer, NextRNA Ink $547Million Deal For Cancer Therapies
This summer, Bayer officials made sure Fierce understood that the company's desire for deals hasn't been stifled by a group-wide reorganization. Its most recent...
New Endometrial Cancer Care Phase II Results Encouraging
The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...